Cari,
ho scritto alla Cosmopharma e questa è la risposta in merito al cb 03 01
Dear Mr. xxx,
I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
A previous Phase II European study in facial acne vulgaris (EudraCT 2008-004335-37) was completed in July 2009, and the results have been published on British Medical Journal 2011;165:177-83.
As concerns the possible US launch, we maintain our deadline for 2015.
Kind regards
Giuseppe Celasco, MD
Chief Medical Officer
Come al solito c'è da aspettare ma potrebbe essere un'arma in più...
ho scritto alla Cosmopharma e questa è la risposta in merito al cb 03 01
Dear Mr. xxx,
I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
A previous Phase II European study in facial acne vulgaris (EudraCT 2008-004335-37) was completed in July 2009, and the results have been published on British Medical Journal 2011;165:177-83.
As concerns the possible US launch, we maintain our deadline for 2015.
Kind regards
Giuseppe Celasco, MD
Chief Medical Officer
Come al solito c'è da aspettare ma potrebbe essere un'arma in più...